Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer's Disease.

Ricard López Ortega,Farida Dakterzada,Alfonso Arias, Ester Blasco,Alba Naudí,Francisco Purroy Garcia,Gerard Piñol-Ripoll

Current aging science（2019）

引用 8|浏览9

暂无评分

摘要

The use of CSF AD biomarkers in clinical practice improves the certainty of diagnosis and prognosis of patients, especially in patients in the prodromal phase or in patients with atypical presentations.

查看译文

关键词

Alzheimer's disease,amyloid,biomarkers,cerebrospinal fluid,mild cognitive impairment,prodromal phase.

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要